Baxter International Inc - Asset Resilience Ratio

Latest as of September 2025: 8.19%

Baxter International Inc (BAX) has an Asset Resilience Ratio of 8.19% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Baxter International Inc (BAX) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$1.73 Billion
Cash + Short-term Investments

Total Assets

$21.07 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how Baxter International Inc's Asset Resilience Ratio has changed over time. See Baxter International Inc (BAX) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Baxter International Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Baxter International Inc.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $1.73 Billion 8.19%
Short-term Investments $0.00 0%
Total Liquid Assets $1.73 Billion 8.19%

Asset Resilience Insights

  • Limited Liquidity: Baxter International Inc maintains only 8.19% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Baxter International Inc Industry Peers by Asset Resilience Ratio

Compare Baxter International Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Alcon AG
SW:ALC
Medical Instruments & Supplies 0.26%
iRay Technology Co Ltd
SHG:688301
Medical Instruments & Supplies 0.68%
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
Medical Instruments & Supplies 29.19%
Jiangsu Nanfang Medical
SHG:603880
Medical Instruments & Supplies 2.27%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
I.Ceram SA
PA:ALICR
Medical Instruments & Supplies -1.61%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%

Annual Asset Resilience Ratio for Baxter International Inc (2009–2024)

The table below shows the annual Asset Resilience Ratio data for Baxter International Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 6.84% $1.76 Billion $25.78 Billion -4.45pp
2023-12-31 11.30% $3.19 Billion $28.28 Billion +5.22pp
2022-12-31 6.07% $1.72 Billion $28.29 Billion -2.73pp
2021-12-31 8.80% $2.95 Billion $33.52 Billion -9.83pp
2020-12-31 18.63% $3.73 Billion $20.02 Billion +0.30pp
2019-12-31 18.33% $3.33 Billion $18.19 Billion +6.64pp
2018-12-31 11.69% $1.84 Billion $15.72 Billion -8.14pp
2017-12-31 19.84% $3.39 Billion $17.11 Billion +1.82pp
2016-12-31 18.02% $2.80 Billion $15.55 Billion -6.54pp
2015-12-31 24.56% $5.15 Billion $20.96 Billion --
2014-12-31 0.00% $0.00 $26.14 Billion --
2013-12-31 0.00% $0.00 $25.22 Billion --
2012-12-31 0.00% $0.00 $20.39 Billion --
2011-12-31 0.00% $0.00 $19.07 Billion --
2010-12-31 0.00% $0.00 $17.49 Billion --
2009-12-31 0.00% $0.00 $17.35 Billion --
pp = percentage points

About Baxter International Inc

NYSE:BAX USA Medical Instruments & Supplies
Market Cap
$8.85 Billion
Market Cap Rank
#2436 Global
#862 in USA
Share Price
$17.21
Change (1 day)
-2.10%
52-Week Range
$15.80 - $31.88
All Time High
$85.36
About

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more